Luminex Corp. (LMNX) Tops Q1 EPS by 21c, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures steady as oil jumps to two-week high ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's Russian supply announcements
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- Iren shares jump 5% in premarket trade on report of Anthropic AI cloud deal
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Enovix posts $11M in Q3 revenue, beats guidance by 10%
- Deutsche Bank Upgrades AST Spacemobile (ASTS) to Buy
- Stryker invests $400M in CMR Surgical with option to acquire
Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance
May 1, 2017 4:05 PM EDTAUSTIN, Texas, May 1, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced financial results for the first quarter of 2017. Financial and operating highlights for the quarter include the following:
Consolidated revenue of $77.8 million, an increase of 23% compared to the first quarter 2016. Total Verigene related revenue of $10.5 million; growth of 59% over its first quarter 2016. Corporate gross margin increased to 68% from 61% in the fourth quarter, 2016 primarily due to overall product mix and improving gross margins on our automated sample to answer molecular products. GAAP net income of $9.2... More


